CSPC Pharmaceutical Group (HKG:1093) reported a profit attributable to shareholders of 3.78 billion yuan for the nine months ended Sept. 30, down 15.9% from 4.49 billion yuan a year ago.
Earnings per share were 0.3203 yuan, compared with 0.3783 yuan a year earlier, according to a Friday filing with the Hong Kong Exchange.
Revenue for the period was 22.7 billion yuan, a 4.9% decrease from 23.9 billion yuan in the year-ago period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.